MimiVax Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2M
Latest Deal Amount
  • Investors
  • 4

MimiVax General Information


Developer of immunotherapeutic vaccines and targeted therapies designed to control tumor growth and recurrence. The company's vaccines use survivin-targeting technology to target a cell-survival protein present in most cancers, enabling healthcare providers to cure their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Elm & Carlton Streets
  • Buffalo, NY 14263
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MimiVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 24-Jun-2020 $2M 0000 Completed Clinical Trials - Phase 2
5. Later Stage VC 02-Aug-2019 0000 Cancelled Clinical Trials - Phase 2
4. Early Stage VC 000 000 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 25-Aug-2015 00.000 000 Completed Startup
2. Grant 01-Mar-2015 $2M $450K Completed Startup
1. Seed Round 01-Jan-2012 $450K $450K Completed Startup
To view MimiVax’s complete valuation and funding history, request access »

MimiVax Executive Team (4)

Name Title Board Seat Contact Info
Michael Ciesielski Ph.D Co-Founder, Chief Executive Officer & Chief Scientific Officer
Robert Fenstermaker MD Co-Founder & Chief Medical Officer
Scott Friedman JD Co-Founder, General Counsel & Board Member
Anil Goyal Ph.D Chief Business Officer
To view MimiVax’s complete executive team members history, request access »

MimiVax Board Members (3)

Name Representing Role Since
David Hohn Self Board Member 000 0000
Jeremy Jacobs Jr. Self Board Member 000 0000
Scott Friedman JD MimiVax Co-Founder, General Counsel & Board Member 000 0000
To view MimiVax’s complete board members history, request access »

MimiVax Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Jerry Jacobs Angel (individual) Minority 000 0000 000000 0
Varia Ventures Venture Capital Minority 000 0000 000000 0
Buffalo Capital Partners Impact Investing Minority 000 0000 000000 0
Roswell Park Cancer Institute Corporation Minority 000 0000 000000 0
To view MimiVax’s complete investors history, request access »